<DOC>
	<DOCNO>NCT00914290</DOCNO>
	<brief_summary>To explore safety efficacy IPX056 compare baclofen tablet alleviation symptom spasticity associate multiple sclerosis ( MS ) .</brief_summary>
	<brief_title>A Study With IPX056 Subjects With Spasticity Associated With Multiple Sclerosis</brief_title>
	<detailed_description>IPX056 compare commercially available tablet design provide prolonged duration absorption reduce dose frequency and/or provide prolong duration antispasticity effect .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<criteria>Male female least 18 year old . Agrees use medically acceptable method contraception throughout study Diagnosed MS define Poser McDonald Criteria . Receiving commercial baclofen tablet stable total daily dose range 15 mg 80 mg TID dose regimen least 4 week prior Screening Visit result improved spasticity . Willing wash remain antispasticity medication study . If female , subject pregnant , plan become pregnant , breastfeed . History allergy severe intolerance baclofen . Did respond previous baclofen treatment formulation . Has experience exacerbation MS within 1 month . Urinary tract infection ( UTI ) within 2 week two symptomatic UTIs within 6 month prior study . Subjects clinically significant impairment renal function History active seizure disorder epilepsy , currently take anticonvulsant treatment control seizure . Other condition cause spasticity ( e.g. , stroke , cerebral palsy , traumatic brain injury ) rigidity ( e.g . Parkinson 's Disease ) . Treated Botulinum Toxin Type A B within previous 4 month , phenol therapeutic alcohol nerve block within 12 month plan use drug study . Has clinically significant limitation passive range motion low extremity . Has major surgery within 6 month prior Screening Visit may affect spasticity assessment abdominal surgery , back surgery , low leg knee surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>